Compounds > h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide
Page last updated: 2024-09-03

h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide and tridodecylmethylammonium

h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide has been researched along with tridodecylmethylammonium in 1 studies

Compound Research Comparison

Studies
(h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide)		Trials
(h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide)		Recent Studies (post-2010)
(h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide)		Studies
(tridodecylmethylammonium)		Trials
(tridodecylmethylammonium)		Recent Studies (post-2010) (tridodecylmethylammonium)
6004726

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greco, RS; Harvey, RA; Kim, HC; Pincus, J; Trooskin, SZ; Wilcox, JN1

Other Studies

1 other study(ies) available for h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide and tridodecylmethylammonium

ArticleYear
Binding of tissue plasminogen activator to vascular grafts.
    Thrombosis and haemostasis, 1989, Feb-28, Volume: 61, Issue:1

    Topics: Antigens; Blood Vessel Prosthesis; Chromogenic Compounds; Humans; Oligopeptides; Polymers; Quaternary Ammonium Compounds; Surface Properties; Surface-Active Agents; Thrombelastography; Tissue Plasminogen Activator

1989